Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Famotidine poisoning (disorder) |
Causative agent (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental famotidine poisoning |
Causative agent (attribute) |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional famotidine poisoning |
Causative agent (attribute) |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la famotidine d'intention indéterminée |
Causative agent (attribute) |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Famotidine adverse reaction |
Causative agent (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to famotidine |
Causative agent (attribute) |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Famotidine overdose |
Causative agent (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental famotidine overdose |
Causative agent (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional famotidine overdose |
Causative agent (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de famotidine d'intention indéterminée |
Causative agent (attribute) |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely famotidine 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Famotidine 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Famotidine 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Famotidine 400mcg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely famotidine 8 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Famotidine 10mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Famotidine 10mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing famotidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely famotidine 10 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely famotidine 20 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely famotidine 40 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental famotidine poisoning |
Causative agent (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional famotidine poisoning |
Causative agent (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Calcium carbonate + famotidine + magensium hydroxide (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Famotidine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Famotidine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to famotidine |
Causative agent (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely famotidine 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely famotidine 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Famotidine 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Famotidine 40 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Famotidine 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Famotidine 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely famotidine 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Famotidine 40 mg oral tablet |
Has precise active ingredient |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Famotidine 10 mg oral tablet |
Has precise active ingredient |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Calcium carbonate and famotidine and magnesium hydroxide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only famotidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only famotidine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Famotidine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely famotidine 10 milligram/1 each conventional release chewable tablet (clinical drug) |
Has precise active ingredient |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely famotidine 10 milligram/1 each conventional release chewable tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely famotidine 8 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely famotidine 8 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely famotidine 20 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely famotidine 20 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely famotidine 40 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely famotidine 40 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only calcium carbonate and famotidine and magnesium hydroxide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) |
Has precise active ingredient |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only famotidine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Calcium carbonate- and famotidine- and magnesium hydroxide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing famotidine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |